Inpatient and outpatient opioid requirements after total joint replacement are strongly influenced by patient and

Austin J Roebke1, Garrhett G Via2, Joshua S Everhart3

  • 1Department of Orthopaedics, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.

Bone & Joint Open
|November 20, 2020
PubMed

Insights

Total knee arthroplasty (TKA) patients require more opioids post-surgery than total hip arthroplasty (THA) patients. Surgical factors and patient characteristics, not anesthesia or non-opioid drugs, predict opioid needs after joint replacement.

Area of Science:

  • Orthopedic Surgery
  • Pain Management
  • Pharmacology

Background:

  • Comprehensive national guidelines for analgesic strategies after total joint replacement are lacking.
  • Understanding opioid requirements after total hip arthroplasty (THA) and total knee arthroplasty (TKA) is crucial for optimizing patient care.
  • Identifying risk factors for increased inpatient and outpatient opioid use is essential for developing targeted pain management protocols.

Purpose of the Study:

  • To compare inpatient and outpatient opioid requirements following THA versus TKA.
  • To identify risk factors influencing opioid consumption after total hip or knee arthroplasty.
  • To evaluate the impact of regional nerve blocks (RNB), neuraxial anesthesia (NA), and non-opioid medications on opioid demand.

Main Methods:

  • Analysis of outcomes in 92 primary THA (n=43) and TKA (n=49) patients, excluding those with repeat surgery within 90 days.
  • Recording of inpatient and 90-day postoperative opioid use, including total consumption, refills, and use beyond 90 days.
  • Multivariate modeling to assess the influence of surgery type, anesthesia, non-opioid medications, demographics, length of stay, and baseline opioid use.

Main Results:

  • TKA patients exhibited significantly higher daily inpatient opioid use (median 12.0 vs 7.0) and greater 90-day use (median 224.0 vs 100.5) compared to THA patients.
  • TKA patients were more likely to require opioid refills (84% vs 33%) and had a higher risk of use beyond 90 days (adjusted OR 7.64).
  • Inpatient opioid use 24 hours before discharge was the strongest predictor of 90-day opioid use; surgical procedure, demographics, and baseline use were more influential than anesthesia or non-opioid analgesics.

Conclusions:

  • Opioid use following TKA and THA is primarily predicted by surgical and patient-specific factors.
  • Total knee arthroplasty is associated with substantially higher postoperative opioid requirements than total hip arthroplasty.
  • Regional nerve blocks, neuraxial anesthesia, and common non-opioid medications did not significantly reduce total inpatient or 90-day postoperative opioid consumption.
Abstract

Related Concept Videos

Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
162
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
625
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
699
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.2K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
99
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.3K